Helen Coco Cook, PHARMD | |
3300 Honolulu Ave, La Crescenta, CA 91214-3329 | |
(818) 330-8920 | |
(818) 279-0622 |
Full Name | Helen Coco Cook |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 3300 Honolulu Ave, La Crescenta, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558703124 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 30890 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Helen Coco Cook, PHARMD 3300 Honolulu Ave, La Crescenta, CA 91214-3329 Ph: (818) 317-0768 | Helen Coco Cook, PHARMD 3300 Honolulu Ave, La Crescenta, CA 91214-3329 Ph: (818) 330-8920 |
News Archive
A new type of gene-editing tool, CRISPR-Cas13, has shown promise in RNA targeting. Previous studies have shown the tool as a potential treatment method for viral diseases, including coronavirus disease (COVID-19).
Study results published in the May 17th issue of Circulation, the journal of the American Heart Association, found that the diabetes medication pioglitazone HCl reduced carotid artery intima-media thickness (IMT). Patients taking pioglitazone also experienced significant reductions in insulin resistance, C-reactive protein (a marker for inflammation) and blood pressure, all of which contribute to the overall risk for cardiovascular disease.
Bristol-Myers Squibb Company and AstraZeneca today announced results from a randomized, double blind Phase 3 clinical study, which demonstrated that the addition of the investigational drug dapagliflozin to existing glimepiride (sulphonylurea) therapy produced significant reductions in glycosylated hemoglobin levels (HbA1c) in adult patients with type 2 diabetes compared to glimepiride alone.
Researchers have discovered that tumors release fatty acids that interfere with the cells that are trying to kill them. Consequently, strategies that reduce the amount of fatty acids surrounding the tumors may give a boost to anti-cancer therapeutics.
› Verified 1 days ago
Sophia Chorbadjian, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5221 Ramsdell Ave, La Crescenta, CA 91214 Phone: 310-903-3903 | |
Dr. Meghedi Gharakhanian, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3001 Foothill Blvd, La Crescenta, CA 91214 Phone: 818-571-7840 Fax: 818-541-7846 | |
Ara Simanian, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3001 Foothill Blvd, La Crescenta, CA 91214 Phone: 818-541-7840 | |
Narine Gavoutian, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2647 Foothill Blvd, La Crescenta, CA 91214 Phone: 818-248-1016 | |
Bolis Batou, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2647 Foothill Blvd, La Crescenta, CA 91214 Phone: 818-248-1016 Fax: 818-248-0023 | |
Albert Won, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5128 Circle Vista Avenue, La Crescenta, CA 91214 Phone: 818-585-3152 | |
Elen Kanayan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3001 Foothill Blvd, La Crescenta, CA 91214 Phone: 181-854-1784 |